Department of Urology, University of California, Irvine Medical Center; Orange, CA; MD/PhD Scholars Program, University of Nebraska Medical Center, Omaha, NE.
Department of Urology, University of California, Irvine Medical Center; Orange, CA.
Urology. 2021 Jun;152:15-24. doi: 10.1016/j.urology.2021.01.066. Epub 2021 Mar 8.
Defining risks associated with diabetes mellitus (DM) in patients undergoing penile prosthesis (PP) implantation remains controversial. This systematic review seeks to assess whether preoperative hemoglobin a1c (HbA1c) or serum glucose have been shown to predict infection following PP implantation in diabetic men. A stepwise literature search was performed. Eight and four studies assessing HbA1c and serum glucose respectively were included. Overall, data exploring HbA1c and serum glucose on PP infection were heterogeneous in time period, study design, and patient populations. Contemporary studies did not support either HbA1c nor blood glucose as predictors of PP infection in diabetic men.
定义接受阴茎假体（PP）植入术的糖尿病（DM）患者相关风险仍然存在争议。本系统评价旨在评估术前糖化血红蛋白（HbA1c）或血清葡萄糖是否可预测糖尿病男性 PP 植入后的感染。逐步进行文献检索。共纳入 8 项和 4 项分别评估 HbA1c 和血清葡萄糖的研究。总体而言，HbA1c 和血清葡萄糖与 PP 感染相关的数据在时间段、研究设计和患者人群方面存在异质性。当代研究均不支持 HbA1c 或血糖可预测糖尿病男性的 PP 感染。
